Rayvisc has been developed with a specific molecular weight and viscosity to effectively maintain the anterior chamber while also protecting the delicate structures of the eye.
Rayvisc, NaHA 3.0%
• Designed for excellent endothelial protection
• Low molecular weight, high NaHA concentration
• Assures the maximum protection and viscosity
• Good maintenance of anterior chamber
